Surgery only? Multimodal treatment for urothelial carcinoma of the bladder

被引:1
作者
Schuettfort, Victor [1 ]
Shariat, Shahrokh F. [2 ]
Rink, Michael [1 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Urol, Martinistr 52, D-20246 Hamburg, Germany
[2] Klinikum Med Univ Wien, Univ Klin Urol, Allgemeines Krankenhaus Stadt Wien, Vienna, Austria
关键词
Urothelial carcinoma; Multimodal therapy; Perioperative chemotherapy; Radical cystectomy; Trimodal therapy; LONG-TERM OUTCOMES; TRANSITIONAL-CELL CARCINOMA; COMBINED-MODALITY TREATMENT; EORTC RISK TABLES; RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; PROGNOSTIC-FACTORS; PRESERVATION THERAPY;
D O I
10.1055/a-1146-2938
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Radical cystectomy is the gold standard in treatment of muscle invasive bladder carcinoma. Especially for patients with advanced tumours, multimodal therapies play an important role in optimising patient care. In older patients with multiple comorbidities, who are not eligible for surgery, alternative treatment modalities are needed as well. This article summarises the current literature on multimodal treatment options in a neoadjuvant and adjuvant setting and analyses alternative potentially curative treatments. The article also summarises the initial results using checkpoint inhibitors in a multimodal treatment setting.
引用
收藏
页码:353 / 362
页数:10
相关论文
共 89 条
[1]   Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC [J].
Aldhaam, Naif A. ;
Elsayed, Ahmed S. ;
Jing, Zhe ;
Richstone, Lee ;
Wagner, Andrew A. ;
Rha, Koon Ho ;
Yuh, Bertram ;
Palou, Juan ;
Khan, Muhammad Shamim ;
Menon, Mani ;
Roupret, Morgan ;
Balbay, Derya ;
Hosseini, Abolfazl ;
Wiklund, Peter ;
Gaboardi, Franco ;
Maatman, Thomas J. ;
Mottrie, Alexandre ;
Wijburg, Carl ;
Stockle, Michael ;
Hemal, Ashok ;
Kim, Eric ;
Kaouk, Jihad ;
Hussein, Ahmed A. ;
Guru, Khurshid A. .
JOURNAL OF UROLOGY, 2020, 203 (01) :57-61
[2]   Palliative Radiation Therapy in Bladder Cancer-Importance of Patient Selection: A Retrospective Multicenter Study [J].
Ali, Amin ;
Song, Yee Pei ;
Mehta, Shaveta ;
Mistry, Hitesh ;
Conroy, Ruth ;
Coyle, Catherine ;
Logue, John ;
Tran, Anna ;
Wylie, James ;
Janjua, Tanzeel ;
Joseph, Lisa ;
Joseph, Joji ;
Choudhury, Ananya .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (02) :389-393
[3]  
[Anonymous], 1999, J Urol, V162, P623
[4]   Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials [J].
Arcangeli, G. ;
Strigari, L. ;
Arcangeli, S. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 95 (03) :387-396
[5]   Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes [J].
Boeri, Luca ;
Soligo, Matteo ;
Frank, Igor ;
Boorjian, Stephen A. ;
Thompson, R. Houston ;
Tollefson, Matthew ;
Quevedo, Fernando J. ;
Cheville, John C. ;
Karnes, R. Jeffrey .
EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (04) :390-396
[6]   Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data [J].
Bono, AV ;
Goebell, PJ ;
Groshen, S ;
Lehmann, J ;
Studer, U ;
Torti, FM ;
Abol-Enein, H ;
Bassi, P ;
Boyer, M ;
Coppin, CML ;
Cortesi, E ;
Hall, RR ;
Horwich, A ;
Malmström, PU ;
Martínez-Piñeiro, JA ;
Sengelov, L ;
Sherif, A ;
Wallace, DMA ;
Clarke, NW ;
Roberts, JT ;
Sylvester, R ;
Parmar, MKB ;
Stewart, LA ;
Tierney, JF ;
Vale, CL .
EUROPEAN UROLOGY, 2005, 48 (02) :189-201
[7]   Epidemiology and Risk Factors of Urothelial Bladder Cancer [J].
Burger, Maximilian ;
Catto, James W. F. ;
Dalbagni, Guido ;
Grossman, H. Barton ;
Herr, Harry ;
Karakiewicz, Pierre ;
Kassouf, Wassim ;
Kiemeney, Lambertus A. ;
La Vecchia, Carlo ;
Shariat, Shahrokh ;
Lotan, Yair .
EUROPEAN UROLOGY, 2013, 63 (02) :234-241
[8]   Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials [J].
Caffo, Orazio ;
Thompson, Catherine ;
De Santis, Maria ;
Kragelj, Borut ;
Hamstra, Daniel A. ;
Azria, David ;
Fellin, Gianni ;
Pappagallo, Giovanni L. ;
Galligioni, Enzo ;
Choudhury, Ananya .
RADIOTHERAPY AND ONCOLOGY, 2016, 121 (02) :193-198
[9]   Contemporary Use Trends and Survival Outcomes in Patients Undergoing Radical Cystectomy or Bladder-Preservation Therapy for Muscle-Invasive Bladder Cancer [J].
Cahn, David B. ;
Handorf, Elizabeth A. ;
Ghiraldi, Eric M. ;
Ristau, Benjamin T. ;
Geynisman, Daniel M. ;
Churilla, Thomas M. ;
Horwitz, Eric M. ;
Sobczak, Mark L. ;
Chen, David Y. T. ;
Viterbo, Rosalia ;
Greenberg, Richard E. ;
Kutikov, Alexander ;
Uzzo, Robert G. ;
Smaldone, Marc C. .
CANCER, 2017, 123 (22) :4337-4345
[10]   Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers [J].
Chanza, Nieves Martinez ;
Werner, Lillian ;
Plimack, Elizabeth ;
Yu, Evan Y. ;
Alva, Ajjai S. ;
Crabb, Simon J. ;
Powles, Thomas ;
Rosenberg, Jonathan E. ;
Baniel, Jack ;
Vaishampayan, Ulka N. ;
Berthold, Dominik R. ;
Ladoire, Sylvain ;
Hussain, Syed A. ;
Milowsky, Matthew, I ;
Agarwal, Neeraj ;
Necchi, Andrea ;
Pal, Sumanta K. ;
Sternberg, Cora N. ;
Bellmunt, Joaquim ;
Galsky, Matthew D. ;
Harshman, Lauren C. .
EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (05) :671-679